Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource and expertise. It undertakes hit identification, hit-to-lead and lead optimization projects, and completes drug discovery programmes. Pneumolabs and Sygnature disovery have a strategic alliance in order to offer our clients a fully integrated drug discovery platform.
LGC is a global leader in the laboratory services. It provides products and services across a number of end markets including Pharmaceuticals, Agricultural Biotechnology, Diagnostics, Food, Environment, Government and Academia. They are our preferred partner for PK study bio-analysis.
Northwick Park Institute for Medical Research (NPMIR) is a biomedical research and service organisation focused on the area of regenerative medicine, with particular interest in the respiratory system (trachea), bowel and liver, and wound healing constructs.